Literature DB >> 6233297

T-cell subsets in spinal fluid of multiple sclerosis patients.

O R Hommes, C J Brinkman.   

Abstract

CSF T-cells and T-cell subsets were characterized by monoclonal antibodies in 15 untreated multiple sclerosis (MS) patients, 17 immunosuppressed chronic progressive MS patients and 9 patients with other neurological diseases. A negative correlation was found between total cell numbers and T suppressor cell percentages in untreated and treated MS patients. A negative correlation (r = -0.71) was found between intrathecal IgG levels and T suppressor cell percentages in untreated MS patients. In peripheral blood, no correlation between T-cells and T-cell subsets with IgG levels was found. It is discussed that T-cell subsets and intrathecal IgG levels may be indicators of the activity of the inflammatory process in the brains of chronic progressive MS patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233297     DOI: 10.1016/0165-5728(84)90033-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

Review 1.  T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  F T Rotteveel; C J Lucas
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  Cell count and ratio of helper/inducer to suppressor/cytotoxic T-cells in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  H W Kölmel; C Sudau
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

3.  Cerebrospinal fluid lymphocyte subpopulations in multiple sclerosis.

Authors:  M G Marrosu; C Cianchetti; M G Ennas
Journal:  Ital J Neurol Sci       Date:  1986-02

4.  CD4+ lymphocyte subsets in the cerebrospinal fluid of multiple sclerosis and non-inflammatory neurological diseases.

Authors:  M Zaffaroni; L Gallo; A Ghezzi; C L Cazzullo
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

5.  Cerebrospinal fluid cells in multiple sclerosis and other neurological diseases: an immunocytochemical study.

Authors:  C H Polman; C J de Groot; J C Koetsier; T Sminia; A J Veerman
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.